The cell therapy market is fast growing but comes with high production costs. Using current technology, cell culture monitoring is extremely time-consuming and requires constant observation throughout the entire process, often lasting into weekends. Ovizio, a specialist in cell culture monitoring, has released the new microscopy technology, iLine F, which automates the process.
With the existing manual and automatic counters, scientists have to sample, prepare and count the cells themselves. Ovizio’s technology provides automated, on-screen, in-process viable cell counting that has been proven to increase accuracy, reproducibility and productivity by allowing operators the flexibility to continue with other tasks.
Applicable from R&D to the manufacturing process and quality control, Ovizio’s automated solutions are said to be easy to use, label-free and non-invasive, with real-time high-quality holographic images. Its technology can reduce operational costs by up to 50% and double productivity when compared with current systems.
Several of the company’s microscopy technologies are already commercialised and have been taken up by a range of companies from the Cell Therapy Catapult to Big Pharma.
Ovizio has also recently signed a distribution agreement with Applikon Biotechnology.
